WO2026093452A1 - Composition à base de lait comprenant un gos permettant d'augmenter l'absorption de fer - Google Patents
Composition à base de lait comprenant un gos permettant d'augmenter l'absorption de ferInfo
- Publication number
- WO2026093452A1 WO2026093452A1 PCT/EP2025/081410 EP2025081410W WO2026093452A1 WO 2026093452 A1 WO2026093452 A1 WO 2026093452A1 EP 2025081410 W EP2025081410 W EP 2025081410W WO 2026093452 A1 WO2026093452 A1 WO 2026093452A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- iron
- milk
- composition
- galactooligosaccharide
- based composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/1203—Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
- A23C9/1206—Lactose hydrolysing enzymes, e.g. lactase, beta-galactosidase
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1522—Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- A23C9/203—Dietetic milk products not covered by groups A23C9/12 - A23C9/18 containing bifidus-active substances, e.g. lactulose; containing oligosaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/1592—Iron
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/28—Oligosaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/28—Oligosaccharides
- A23V2250/284—Oligosaccharides, non digestible
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dairy Products (AREA)
Abstract
L'invention concerne des procédés et des compositions qui augmentent l'absorption du fer, par exemple en augmentant la capacité d'absorption du fer et/ou en augmentant la biodisponibilité du fer. L'invention concerne un procédé d'augmentation de l'absorption du fer, de préférence présent naturellement dans un aliment, un repas ou un régime alimentaire à base de plantes, comprenant l'administration à un individu qui en a besoin d'un galactooligosaccharide (GOS) de la composition à base de lait, de préférence une composition à base de lait à faible teneur en lactose et faible teneur en sucre comprenant du galactooligosaccharide (GOS). L'individu, auquel la composition à base de lait est administrée, peut être choisi parmi des adultes ; des personnes âgées ; des femmes enceintes ou allaitantes ; des femmes ménopausées ou periménopausées, des nourrissons ; des enfants ; et des sujets suivant un régime végétarien, un régime flexitarien, un régime végétalien ou tout type de régime à base de plantes.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202463714267P | 2024-10-31 | 2024-10-31 | |
| US63/714,267 | 2024-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2026093452A1 true WO2026093452A1 (fr) | 2026-05-07 |
Family
ID=97598778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2025/081410 Pending WO2026093452A1 (fr) | 2024-10-31 | 2025-10-30 | Composition à base de lait comprenant un gos permettant d'augmenter l'absorption de fer |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2026093452A1 (fr) |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140087021A1 (en) | 2011-05-24 | 2014-03-27 | Nestec S.A | Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides, and a process to produce the composition |
| US20160044945A1 (en) * | 2013-03-22 | 2016-02-18 | N.V. Nutricia | Fermented nutrition high in lactose with increased iron bioavailability |
| US20160050960A1 (en) * | 2013-03-22 | 2016-02-25 | N.V. Nutricia | Fermented nutrition with non-digestible oligosaccharides with increased iron bioavailability |
| US10124016B2 (en) | 2008-06-13 | 2018-11-13 | N.V. Nutricia | Immune system stimulating nutrition |
| EP3624594A1 (fr) | 2017-05-15 | 2020-03-25 | Novozymes A/S | Produits laitiers comprenant de grandes quantités de galacto-oligosaccharides (gos) et leur production |
| CN111466443A (zh) * | 2020-04-14 | 2020-07-31 | 周赛新 | 一种儿童成长营养奶粉 |
| WO2022241163A1 (fr) | 2021-05-13 | 2022-11-17 | Bcd Bioscience, Inc. | Procédés d'utilisation de compositions d'oligosaccharides pour moduler le microbiote et leurs produits métaboliques, et en tant qu'agents thérapeutiques pour des applications de santé |
| US11529364B2 (en) | 2014-12-08 | 2022-12-20 | Glycom A/S | Synthetic composition for treating metabolic disorders |
| WO2023057540A1 (fr) | 2021-10-07 | 2023-04-13 | Société des Produits Nestlé S.A. | Procédé de préparation de compositions alimentaires traitées par voie enzymatique avec gos et faible teneur en lactose et compositions alimentaires correspondantes |
| CN117546915A (zh) * | 2023-12-12 | 2024-02-13 | 陕西科技大学 | 一种功能性绵羊奶粉及其制备方法 |
-
2025
- 2025-10-30 WO PCT/EP2025/081410 patent/WO2026093452A1/fr active Pending
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10124016B2 (en) | 2008-06-13 | 2018-11-13 | N.V. Nutricia | Immune system stimulating nutrition |
| US20140087021A1 (en) | 2011-05-24 | 2014-03-27 | Nestec S.A | Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides, and a process to produce the composition |
| US20160044945A1 (en) * | 2013-03-22 | 2016-02-18 | N.V. Nutricia | Fermented nutrition high in lactose with increased iron bioavailability |
| US20160050960A1 (en) * | 2013-03-22 | 2016-02-25 | N.V. Nutricia | Fermented nutrition with non-digestible oligosaccharides with increased iron bioavailability |
| US11529364B2 (en) | 2014-12-08 | 2022-12-20 | Glycom A/S | Synthetic composition for treating metabolic disorders |
| EP3624594A1 (fr) | 2017-05-15 | 2020-03-25 | Novozymes A/S | Produits laitiers comprenant de grandes quantités de galacto-oligosaccharides (gos) et leur production |
| CN111466443A (zh) * | 2020-04-14 | 2020-07-31 | 周赛新 | 一种儿童成长营养奶粉 |
| WO2022241163A1 (fr) | 2021-05-13 | 2022-11-17 | Bcd Bioscience, Inc. | Procédés d'utilisation de compositions d'oligosaccharides pour moduler le microbiote et leurs produits métaboliques, et en tant qu'agents thérapeutiques pour des applications de santé |
| WO2023057540A1 (fr) | 2021-10-07 | 2023-04-13 | Société des Produits Nestlé S.A. | Procédé de préparation de compositions alimentaires traitées par voie enzymatique avec gos et faible teneur en lactose et compositions alimentaires correspondantes |
| CN117546915A (zh) * | 2023-12-12 | 2024-02-13 | 陕西科技大学 | 一种功能性绵羊奶粉及其制备方法 |
Non-Patent Citations (7)
| Title |
|---|
| ALY ESMAT ET AL: "Supplementation of infant formulas with recombinant human lactoferrin and/or galactooligosaccharides increases iron bioaccessibility as measured by ferritin formed in Caco-2 cell model", FOOD RESEARCH INTERNATIONAL, ELSEVIER, AMSTERDAM , NL, vol. 89, 24 August 2016 (2016-08-24), pages 1048 - 1055, XP029816281, ISSN: 0963-9969, DOI: 10.1016/J.FOODRES.2016.08.030 * |
| CHRISTIDES TATIANA ET AL: "In vitro assessment of iron availability from commercial Young Child Formulae supplemented with prebiotics", EUROPEAN JOURNAL OF NUTRITION, vol. 57, no. 2, 9 December 2016 (2016-12-09), DE, pages 669 - 678, XP093354666, ISSN: 1436-6207, DOI: 10.1007/s00394-016-1353-3 * |
| DIPUN NIRMAL PERERA ET AL: "Factors affecting iron absorption and the role of fortification in enhancing iron levels", NUTRITION BULLETIN, WILEY-BLACKWELL PUBLISHING LTD, GB, vol. 48, no. 4, 15 November 2023 (2023-11-15), pages 442 - 457, XP072537156, ISSN: 1471-9827, DOI: 10.1111/NBU.12643 * |
| GLAHN, R.P. ET AL.: "Caco-2 cell ferritin formation predicts non-radiolabeled food iron availability in an in vitro digestion/Caco-2 cell culture model.", J. NUTR., vol. 128, 1998, pages 1555 - 1561 |
| RAZA, IQBALULLAH, KHANIMRAN: "Enzymatic conversion of milk lactose to prebiotic galactooligosaccharides to produce low lactose yogurt", J FOOD PROCESS PRESERV., vol. 42, 2018, pages e13586, Retrieved from the Internet <URL:https://doi.org/10.1111/jfpp.13586> |
| SCHEUCHZER PORNPIMOL ET AL: "Iron Absorption from an Iron-Fortified Follow-Up Formula with and without the Addition of a Synbiotic or a Human-Identical Milk Oligosaccharide: A Randomized Crossover Stable Isotope Study in Young Thai Children", THE JOURNAL OF NUTRITION, vol. 154, no. 10, October 2024 (2024-10-01), US, pages 2988 - 2998, XP093354668, ISSN: 0022-3166, DOI: 10.1016/j.tjnut.2024.08.016 * |
| TAKASUGI SATOSHI ET AL: "A Combination of a Dairy Product Fermented by Lactobacilli and Galactooligosaccharides Shows Additive Effects on Mineral Balances in Growing Rats with Hypochlorhydria Induced by a Proton Pump Inhibitor", BIOLOGICAL TRACE ELEMENT RESEARCH, HUMANA PRESS, CLIFTON, NJ, US, vol. 153, no. 1, 4 May 2013 (2013-05-04), pages 309 - 318, XP035319089, ISSN: 0163-4984, [retrieved on 20130504], DOI: 10.1007/S12011-013-9681-0 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2356247C2 (ru) | Комбинации и композиции, содержащие жирные кислоты и аминокислоты, их применение для предупреждения, замедления прогрессирования или лечения диабета и связанных с диабетом заболеваний и состояний, способ снижения веса тела млекопитающего, набор | |
| JP6116913B2 (ja) | 栄養組成物 | |
| US20040253227A1 (en) | Perioperative multivitamin protein beverage and additive for use in preparing an individual for fast surgical recovery | |
| US20190335796A1 (en) | Optimized nutrient food | |
| US20060099277A1 (en) | Protein and fruit juice product | |
| AU2004296647B2 (en) | Enteropathy ameliorating composition | |
| RU2391864C2 (ru) | Способ коррекции диеты группы пациентов | |
| EP2627196B1 (fr) | Smoothie à base de produits laitiers pour stimuler la croissance chez des enfants | |
| AU2016269605B2 (en) | Compositions comprising cinnamaldehyde and zinc and methods of using such compositions | |
| RU2525338C2 (ru) | Инстантный функциональный пищевой продукт | |
| AU2024260161A1 (en) | Compositions and methods for improving brain health | |
| WO2026093449A1 (fr) | Compositions et procédés utilisant un galacto-oligosaccharide pour augmenter l'absorption de zinc | |
| WO2026093450A1 (fr) | Compositions et procédés utilisant un galacto-oligosaccharide pour augmenter l'absorption de calcium par amélioration de sa solubilité | |
| JP5006577B2 (ja) | 生活習慣病改善剤 | |
| KR100628539B1 (ko) | 혈압상승 억제 및 혈압강하 효과가 있는 요구르트 조성물 | |
| JP4435882B2 (ja) | アルコール吸収抑制組成物 | |
| TW202034944A (zh) | 一種大豆分離蛋白用於製備預防或治療骨鬆合併肌少症、提升身體機能及降低運動後疲勞之組合物的用途。 | |
| JP2005239686A (ja) | 脂肪燃焼促進組成物及び該組成物を含有する食品又は医薬品 | |
| WO2026093462A1 (fr) | Composition à base de lait à faible teneur en lactose et à faible teneur en sucre comprenant des galactooligosaccharides destinés à être utilisés pour améliorer la santé musculaire chez un nourrisson, un jeune enfant ou un enfant | |
| WO2026052695A1 (fr) | Compositions et procédés d'amélioration de la santé gastrointestinale | |
| Porter | Dietary Treatment of Gastrointestinal Diseases | |
| WO2026093460A1 (fr) | Compositions à base de lait comprenant un gos et procédés utilisant ces compositions pour améliorer la santé osseuse chez un nourrisson, un jeune enfant ou un enfant | |
| WO2026052725A1 (fr) | Ingrédient alimentaire et produits de type boisson | |
| Imma et al. | CALCIUM FROM A CALCIUM-RICH MINERAL WATER: SUPPLEMENTATION AND BIOAVAILABILITY | |
| KR101477765B1 (ko) | 비만의 예방 및 관리에 유용한 식이조성물 |